Loading publications…
The last 5 uploaded publications
Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients
Wijnand K. den Dekker, Jaco H. Houtgraaf, Yoshinobu Onuma, Edouard Benit, Robbert J. de Winter, William Wijns, Manfred Grisold, Stephan Verheye, Sigmund Silber, Emmanuel Teíger, Stephen Rowland, Erik Ligtenberg, Jonathan Hill, Marcus Wiemer, Peter den Heijer, Benno J. Rensing, Keith M. Channon, Patrick W. Serruys, Henricus J. Duckers (2011). Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients. Atherosclerosis, 219(1), pp. 245-252, DOI: 10.1016/j.atherosclerosis.2011.06.032.
Article146 days agoAssessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.
Johan H. C. Reiber, Patrick W. Serruys, C. J. Kooijman, William Wijns, C. J. Slager, Jan J. Gerbrands, Johan C.H. Schuurbiers, Ad den Boer, Philip Hugenholtz (1985). Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.. Circulation, 71(2), pp. 280-288, DOI: 10.1161/01.cir.71.2.280.
Article146 days agoComparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents
Patrick W. Serruys, Sigmund Silber, Scot Garg, Robert‐Jan van Geuns, Gert Richardt, Paweł Buszman, Henning Kelbæk, Adrianus J. van Boven, Sjoerd H. Hofma, Axel Linke, Volker Klauß, William Wijns, Carlos Macaya, Philippe Garot, Carlo Di Mario, Ganesh Manoharan, Ran Kornowski, Thomas Ischinger, Antonio L. Bartorelli, Jacintha E. Ronden, Marco Bressers, Pierre Gobbens, Manuela Negoita, Frank N. van Leeuwen, Stephan Windecker (2010). Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents. New England Journal of Medicine, 363(2), pp. 136-146, DOI: 10.1056/nejmoa1004130.
Article146 days agoBiolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
Stephan Windecker, Patrick W. Serruys, Simon Wandel, Paweł Buszman, Stanisław Trznadel, Axel Linke, Karsten Lenk, Thomas Ischinger, Volker Klauß, Franz R. Eberli, Roberto Corti, William Wijns, Marie‐Claude Morice, Carlo Di Mario, Simon Davies, Robert‐Jan van Geuns, Pedro Eerdmans, Gerrit-Anne van Es, Bernhard Meier, Peter Jüni (2008). Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. The Lancet, 372(9644), pp. 1163-1173, DOI: 10.1016/s0140-6736(08)61244-1.
Article146 days agoEffects of the Direct Lipoprotein-Associated Phospholipase A <sub>2</sub> Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque
Patrick W. Serruys, Héctor M. García‐García, Paweł Buszman, Paul Erné, Stefan Verheye, Michael Aschermann, Henrikus Duckers, Øyvind Bleie, Dariusz Dudek, Hans Erik Bøtker, Clemens von Birgelen, Don D'Amico, Tammy Hutchinson, Andrew Zambanini, Frits Mastik, Gerrit-Anne van Es, Antonius F.W. van der Steen, D. Geoffrey Vince, Peter Ganz, Christian W. Hamm, William Wijns, Andrew Zalewski (2008). Effects of the Direct Lipoprotein-Associated Phospholipase A <sub>2</sub> Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque. Circulation, 118(11), pp. 1172-1182, DOI: 10.1161/circulationaha.108.771899.
Article146 days ago